Omnicell
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Omnicell and other ETFs, options, and stocks.About OMCL
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation.
OMCL Key Statistics
Stock Snapshot
With a market cap of 1.93B, Omnicell(OMCL) trades at $43.06. The stock has a price-to-earnings ratio of 101.99.
On 2025-12-11, Omnicell(OMCL) stock moved within a range of $42.99 to $44.65. With shares now at $43.06, the stock is trading +0.2% above its intraday low and -3.6% below the session's peak.
Trading volume for Omnicell(OMCL) stock has reached 198.76K, versus its average volume of 628.74K.
Over the past 52 weeks, Omnicell(OMCL) stock has traded between a high of $47.69 and a low of $22.66.
Over the past 52 weeks, Omnicell(OMCL) stock has traded between a high of $47.69 and a low of $22.66.
OMCL News
Omnicell recently launched Omnicell Titan XT in the United States, an enterprise-grade automated dispensing system powered by its cloud-based, HITRUST-certified...
BofA analyst Allen Lutz raised the firm’s price target on Omnicell (OMCL) to $46 from $36 and keeps a Neutral rating on the shares after the company announced y...
Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks...
Analyst ratings
63%
of 8 ratingsMore OMCL News
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...
Omnicell (OMCL) has quietly put together a stronger stretch of performance, with the stock up about 11% over the past week and roughly 25% in the past 3 months,...
Omnicell’s OMCL strength in its SaaS and Expert Services offerings should help sustain growth in the upcoming quarters. Efforts to expand into overseas markets...